| Original language | English (US) |
|---|---|
| Pages (from-to) | 304-305 |
| Number of pages | 2 |
| Journal | Cell Stem Cell |
| Volume | 25 |
| Issue number | 3 |
| DOIs | |
| State | Published - Sep 5 2019 |
Bibliographical note
Funding Information:On a pro bono basis, L.T. submitted an expert opinion report supporting claims of plaintiffs in litigation filed against the Lung Institute's Florida clinic. J.E.J.R. has received honoraria or speaker's fees from GSK, Takeda, Gilead, Cynata, Pfizer, Spark, Novartis, Celgene, and bluebird bio; owned stock in Genea and serves as Director of Pathology; and received equity in Rarecyte in lieu of fees.